Help Put Suicide Risks With ADHD Meds Into Perspective

Patients or parents will ask about the new Health Canada warnings for ADHD drugs and the risk of suicidal thoughts and behaviours.

These will be similar to the existing warnings for the nonstimulant ADHD drug, atomoxetine (Strattera, etc).

The new warnings will alert patients about reports of suicidal thoughts, suicide attempts, and completed suicides with all other ADHD drugs, such as amphetamines (Adderall XR, etc), methylphenidate (Ritalin, etc), and guanfacine (Intuniv XR).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote